Switching from Monthly to Three-Monthly Long-Acting Injectable Paliperidone: A Survey on Subjective Satisfaction and Safety

INTRODUCTION: Poor adherence to antipsychotic medication is common in the treatment of schizophrenia and other psychotic disorders. Paliperidone palmitate 3-monthly (PP3M) is the first long-acting injectable (LAI) antipsychotic to allow for only four medication administrations per year, and although...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnett, Joshua, Pappa, Sofia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350408/
https://www.ncbi.nlm.nih.gov/pubmed/37465056
http://dx.doi.org/10.2147/PPA.S410028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350408/
https://www.ncbi.nlm.nih.gov/pubmed/37465056
http://dx.doi.org/10.2147/PPA.S410028

Ejemplares similares